CERO – cero therapeutics holdings, inc. (US:NASDAQ)
Stock Stats
News
CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia
CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity
CERo Therapeutics files to sell 713.6M shares of common stock for holders [Seeking Alpha]
CERo Therapeutics, Inc. Provides Corporate Update
CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer
Form 424B3 CERO THERAPEUTICS HOLDIN
Form 424B3 CERO THERAPEUTICS HOLDIN
Form SC 13G/A CERO THERAPEUTICS HOLDIN Filed by: SLOAN STUART M
Form 4 CERO THERAPEUTICS HOLDIN For: Sep 25 Filed by: SLOAN STUART M
Form 3 CERO THERAPEUTICS HOLDIN For: Sep 24 Filed by: SLOAN STUART M
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.